Neuroscience: from molecular mechanisms to disease
BIO-480
17/11: Therapeutic strategies against synucleinopathies
This page is part of the content downloaded from 17/11: Therapeutic strategies against synucleinopathies on Sunday, 25 January 2026, 03:52. Note that some content and any files larger than 50 MB are not downloaded.
Files and subfolders
- Multiple choice questions_Multiple choices_Answers.docx
- Multiple choice questions_Multiple choices.docx
- Multiple choice questions_Single choice_answers.docx
- Multiple choice questions_Single choice.docx
- Therapeutic approaches in Synucleinopathies_open question_Answers.docx
- Therapeutic approaches in Synucleinopathies_open questions.docx
- LAG3 is not expressed in neurons.pdf
- Pathological a-synuclein and LAG3.pdf
- Impact of academic publication in therapeutic strategy_171125_Part II.pdf
- Therapeutic strategies against synucleinopathies_17_11_25.pdf
- Why_Parkinson_s_Drug_Trials_Keep_Failing.m4a